• Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of adipose-derived mesenchymal stem cell injections to treat mouth fibrosis in patients with systemic scleroderma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Sweden
  • Study of botulinum toxin injections to treat pain in patients with piriformis muscle syndrome

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France
  • Long-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland
  • Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

    Not yet recruiting

    2 1 1 1
    Austria Belgium Czechia France Germany Ireland +2
  • Safety and effectiveness study of PN6047 HCl in adults with peripheral neuropathic pain and mechanical allodynia

    Not yet recruiting

    2 1
    Czechia Poland Spain
  • Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark France Germany The Netherlands
  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Belgium

powered by